Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
1998-11-17
pubmed:abstractText
We identified SH2-Balpha as an insulin-receptor-binding protein based on interaction screening in yeast hybrid systems and co-precipitation in cells. SH2-Balpha contains pleckstrin-homology ('PH') and Src homology 2 (SH2) domains and is closely related to APS (adapter protein with a PH domain and an SH2 domain) and lnk, adapter proteins first identified in lymphocytes. SH2-Balpha is ubiquitously expressed and is present in rat epididymal adipose tissue, liver and skeletal muscle, physiological sites of insulin action. On SDS/PAGE, SH2-Balpha migrates at a molecular mass of 98 kDa, although the predicted size of SH2-Balpha is 79.6 kDa. Insulin causes an electrophoretic mobility shift. SH2-Balpha can be immunoprecipitated using anti-(insulin receptor) antibody from insulin-stimulated cells. Anti-phosphotyrosine antibody or the growth factor receptor-binding protein 2 (Grb2) SH2 domain precipitate SH2-Balpha after insulin stimulation, suggesting that SH2-Balpha is tyrosine-phosphorylated and may be a substrate for the insulin receptor. The SH2-Balpha SH2 domain did not interact with insulin-receptor substrate (IRS) proteins or epidermal-growth-factor receptor. Mutation of the juxtamembrane and C-terminus of the insulin receptor did not abolish the interaction with the SH2 domain. This was further confirmed using a panel of activation-loop single point mutants where mutation of Tyr1158, Tyr1162 and Tyr1163 abolished interaction. Thus SH2-Balpha is a likely component in the insulin-signalling pathway and may function as an alternative signalling protein by interacting with the activation loop of the insulin-receptor cytoplasmic domain.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-2159147, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-2449432, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-2859121, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-3178737, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7479769, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7486683, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7513704, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7525547, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7537849, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7559478, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-7935368, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8058065, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8276809, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8524815, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8621530, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8622870, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8662806, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-8798417, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9006901, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9062339, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9204766, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9233773, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9312016, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9343427, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9360986, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9369444, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9452421, http://linkedlifedata.com/resource/pubmed/commentcorrection/9742218-9636306
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0264-6021
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
335 ( Pt 1)
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
103-9
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
SH2-Balpha is an insulin-receptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase.
pubmed:affiliation
Cell Signalling Laboratory, Department of Metabolic Medicine, Imperial College School of Medicine-Hammersmith Campus, 150 Du Cane Road, London W12 0NN, UK.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't